EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation

Stella L Gerber, Matthias Diebold iD, Gideon Hönger iD, Caroline Wehmeier iD, Thomas Wolff, Edin Mujagic iD, Corinne Widmer iD, Andreas Buser iD, Stefan Schaub iD

HLA · 2026-11 · 108 (5)

DOI: 10.1111/tan.71068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, online erschienen am 05.11.2026. Verfasst von Stella L Gerber und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Kidney Transplantation, HLA Antigens, Graft Rejection, Isoantibodies. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whether erythrocyte transfusion (ET) after kidney transplantation triggers formation of de novo donor‐specific HLA‐antibodies (HLA‐DSA) and rejection remains debated. If this were true, ET should broaden HLA sensitisation, reflected by increased calculated panel reactive antibodies (cPRA) and de novo HLA‐antibody specificities beyond HLA‐DSA. This has not been investigated in detail yet. In this retrospective study we included 519 kidney transplant recipients having single antigen bead analyses pretransplant and at one‐year posttransplant. ET was assessed both as a binary variable (with/without ET) and in quantity‐based groups (without ET, 1–2 ET, 3–5 ET, > 5 ET). No significant differences were found between patients with/without ET in the one‐year incidence of clinical rejection (19.7% vs. 15.3%, p = 0.43), clinical/subclinical rejection (30.0% vs. 28.6%, p = 0.86), TCMR (15.6% vs. 19.4%; p = 0.30) and AMR (15.6% vs. 10.1%; p = 0.19). Quantity‐based analysis also showed no significant differences, except for higher AMR incidence in patients receiving > 5 ET ( p = 0.03). This association lost significance after multivariable adjustment in a time‐dependent Cox model (HR: 0.91 [95%‐CI: 0.52–1.59]; p = 0.74). De novo HLA‐DSA incidence was similar in patients with/without ET (3.5% vs. 3.1%, p = 0.80) and across quantity‐based groups ( p = 0.17). cPRA change did not differ between patients with/without ET or across quantity‐based groups. No preferential sensitisation against highly prevalent HLA‐antigens Class I was observed (e.g., HLA‐A1 [0.4%], HLA‐A2 [0.8%], HLA‐B51 [0.8%] and HLA‐Cw7 [1.3%]). In conclusion, ET after kidney transplantation under tacrolimus/mycophenolate/prednisone‐based immunosuppression was not associated with rejection, de novo HLA‐DSA formation, and broadened HLA sensitisation arguing against the clinical need for HLA‐matched/selected ET in this setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHLA AntigensGraft RejectionIsoantibodiesErythrocyte TransfusionHumansFemaleMaleRetrospective StudiesMiddle AgedAdultGraft SurvivalHistocompatibility Testing

Stichwörter der Autor:innen

HLA sensitisationallograft rejectionerythrocyte transfusionkidney transplantation

Substanzen

HLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • HLA-Diagnostics and Immunogenetics, Department of Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
  • Department of Vascular and Renal Transplant Surgery, University Hospital Basel, Basel, Switzerland.
  • Department of Hematology and Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
  • Regional Blood Transfusion Service, Swiss Red Cross, Northwestern Switzerland, Basel, Switzerland.

ORCID-Profile: Matthias Diebold, Gideon Hönger, Caroline Wehmeier, Edin Mujagic, Corinne Widmer, Andreas Buser, Stefan Schaub

Zitieren

APA

Gerber, S. L., Diebold, M., Hönger, G., Wehmeier, C., Wolff, T., Mujagic, E., Widmer, C., Buser, A., & Schaub, S. (2026). Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation. HLA, 108(5). https://doi.org/10.1111/tan.71068

Vancouver

Gerber SL, Diebold M, Hönger G, Wehmeier C, Wolff T, Mujagic E, et al. Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation. HLA. 2026;108(5). doi:10.1111/tan.71068

BibTeX
@article{Gerber2026,
  author = {Gerber, Stella L and Diebold, Matthias and Hönger, Gideon and Wehmeier, Caroline and Wolff, Thomas and Mujagic, Edin and Widmer, Corinne and Buser, Andreas and Schaub, Stefan},
  title = {Impact of Blood Transfusions After Kidney Transplantation on Clinical Outcomes and Broadness of Sensitisation},
  journal = {HLA},
  year = {2026},
  volume = {108},
  number = {5},
  doi = {10.1111/tan.71068}
}
Kostenlos starten →